ArticleFrontiers in public health2026
Root cause analysis of the challenges to sustain effectiveness of clinical pharmacist-driven antimicrobial stewardship in a Chinese Tertiary Hospital.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To optimize pharmacist engagement in antimicrobial stewardship (AMS), this study assessed general surgeons' knowledge, practices, and perspectives on AMS and pharmacist interventions. Although antibiotic utilization density has decreased consistently over three years following the involvement of clinical pharmacists, challenges to AMS persist. Methods: This study employed a root cause analysis of interviews with general surgeons at a hospital in Tianjin. The interviews were informed by a questionnaire developed using the Delphi method. Results: The interview analysis identified four key barriers: limited surgeon awareness of AMS guidelines, complex antibiotic selection driven by disease severity, patient-specific clinical factors, and unresolved complex cases requiring tailored approaches. Surgeons proposed four strategic recommendations: (1) refining the AMS system systematically; (2) sustaining AMS outcomes through multifaceted efforts; (3) increasing the frequency of pharmacistsurgeon interactions; and (4) expanding pharmacists clinical roles beyond supervision and training. Discussion: The findings underscore the necessity of enhancing surgeon education on AMS guidelines and policies. Furthermore, increasing the frequency of pharmacistsurgeon collaboration would better support antibiotic selection, adjustment, drug sensitivity test interpretation, and access to specialized treatment information, thereby addressing the clinical complexities hindering the efficacy of AMS. The study also highlights critical pathways to strengthen system-level management strategies amid evolving health care demands.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.